Estimates Revisions Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
03:59:50 2026-10-09 pm EDT
|
5-day change | 1st Jan Change | ||
| 301.96 USD | +1.28% |
|
+3.99% | +51.24% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT
Dividend / Share (DPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
